Application 204688
- Type
- ANDA
- Sponsor
- BRECKENRIDGE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEGESTROL ACETATE | MEGESTROL ACETATE | SUSPENSION;ORAL | 125MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0887 | Megestrol Acetate | Megestrol Acetate | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0887 | Megestrol Acetate | Megestrol Acetate | Pharmaceutical Associates, Inc. | ANDA | Current |
| 51991-313 | Megestrol acetate | MEGESTROL ACETATE | Breckenridge Pharmaceutical, Inc. | ANDA | Current |
| 51991-313 | Megestrol acetate | MEGESTROL ACETATE | Breckenridge Pharmaceutical, Inc. | ANDA | Current |
| 51991-313 | Megestrol acetate | MEGESTROL ACETATE | Breckenridge Pharmaceutical, Inc. | ANDA | Current |